Tag: ENZC
-
Enzolytics’ (ENZC) Virogentics and Biogenysis Sale Transaction, Clinical Trials Progress, and Arican ITV-1 Project Updates: A Closer Look
June 5, 2023. An impressive stride in the biotech industry is made as Enzolytics, Inc. – a pioneer in drug development and a beacon of hope for debilitating infectious diseases – shares updates about the sale of its wholly-owned subsidiaries, Virogentics, Inc. and Biogenysis, Inc., as well as details regarding its ongoing clinical trials approved…